The changing landscape of atherosclerosis

P Libby - Nature, 2021 - nature.com
Emerging evidence has spurred a considerable evolution of concepts relating to
atherosclerosis, and has called into question many previous notions. Here I review this …

Assessment and treatment of patients with type 2 myocardial infarction and acute nonischemic myocardial injury

AP DeFilippis, AR Chapman, NL Mills, JA De Lemos… - Circulation, 2019 - ahajournals.org
Although coronary thrombus overlying a disrupted atherosclerotic plaque has long been
considered the hallmark and the primary therapeutic target for acute myocardial infarction …

An update on lipid oxidation and inflammation in cardiovascular diseases

S Zhong, L Li, X Shen, Q Li, W Xu, X Wang… - Free Radical Biology …, 2019 - Elsevier
Cardiovascular diseases (CVD), including ischemic heart diseases and cerebrovascular
diseases, are the leading causes of morbidity and mortality worldwide. Atherosclerosis is the …

Measurement of reactive oxygen species, reactive nitrogen species, and redox-dependent signaling in the cardiovascular system: a scientific statement from the …

KK Griendling, RM Touyz, JL Zweier, S Dikalov… - Circulation …, 2016 - ahajournals.org
Reactive oxygen species and reactive nitrogen species are biological molecules that play
important roles in cardiovascular physiology and contribute to disease initiation …

Antisense therapy targeting apolipoprotein (a): a randomised, double-blind, placebo-controlled phase 1 study

S Tsimikas, NJ Viney, SG Hughes, W Singleton… - The Lancet, 2015 - thelancet.com
Summary Background Lipoprotein (a)(Lp [a]) is a risk factor for cardiovascular disease and
calcific aortic valve stenosis. No effective therapies to lower plasma Lp (a) concentrations …

Oxidized phospholipids in cardiovascular disease

S Tsimikas, JL Witztum - Nature Reviews Cardiology, 2024 - nature.com
Prolonged or excessive exposure to oxidized phospholipids (OxPLs) generates chronic
inflammation. OxPLs are present in atherosclerotic lesions and can be detected in plasma …

Ancestry, Lipoprotein(a), and Cardiovascular Risk Thresholds: JACC Review Topic of the Week

S Tsimikas, SM Marcovina - Journal of the American College of Cardiology, 2022 - jacc.org
This study reviews ancestral differences in the genetics of the LPA gene, risk categories of
elevated lipoprotein (a)[Lp (a)] as defined by guidelines, ancestry-specific Lp (a) risk …

[HTML][HTML] Lipoprotein (a): truly a direct prothrombotic factor in cardiovascular disease?

MB Boffa, ML Koschinsky - Journal of lipid research, 2016 - Elsevier
Elevated plasma concentrations of lipoprotein (a)[Lp (a)] have been determined to be a
causal risk factor for coronary heart disease, and may similarly play a role in other …

Lipoprotein (a), platelet function and cardiovascular disease

HS Bhatia, RC Becker, G Leibundgut, M Patel… - Nature Reviews …, 2024 - nature.com
Abstract Lipoprotein (a)(Lp (a)) is associated with atherothrombosis through several
mechanisms, including putative antifibrinolytic properties. However, genetic association …

A critical role for plasminogen in inflammation

SK Baker, S Strickland - The Journal of experimental medicine, 2020 - pmc.ncbi.nlm.nih.gov
Plasminogen and its active form, plasmin, have diverse functions related to the inflammatory
response in mammals. Due to these roles in inflammation, plasminogen has been …